Apoptosis of purified CD4+ t cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Kaminitz, Ayelet ^a,b   Askenasy, Enosh M ^c   Yaniv, Isaac ^a   Stein, Jerry ^a   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DEATH; CELL INTERACTION; CELL ISOLATION; CELL MANIPULATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; HOMEOSTASIS; METABOLISM; NONOBESE DIABETIC MOUSE;

MUS;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HOMEOSTASIS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, INBRED NOD;

EID: 79251472114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015684     Document Type: Article

References (63)

1. Shevach EM (2000) Regulatory T cells in autoimmmunity. Annu Rev Immunol 18: 423-449.
2. Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2: 816-822.
3. Bluestone JA, Abbas AK (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253-257.
4. Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
5. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
6. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1106.
7. Herbelin A, Gombert JM, Lepault F, Bach JF, Chatenoud L (1998) Mature mainstream TCR alpha beta+CD4+ thymocytes expressing l-selectin mediate ''active tolerance'' in the nonobese diabetic mouse. J Immunol 161: 2620-2628.
8. Lepault F, Gagnerault MC (2000) Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 164: 240-247.
9. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. (2000) B7/CD28 co-stimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
10. von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6: 338-344.
11. Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13: 108-116.
12. Askenasy N, Kaminitz A, Yarkoni S (2008) Mechanisms of T regulatory cell function. Autoimmun Rev 7: 370-375.
13. Colucci F, Cilio C, Leijon K, Penha Goncalves C, Bergman ML, et al. (1996) Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J Autoimmun 9: 271-276.
14. Radosevic K, Casteels KM, Mathieu C, van Ewijk W, Drexhage H, et al. (1999) Splenic dendritic cells from the nonobese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells? J Autoimmun 13: 373-382.
15. Arreaza G, Salojin K, Yang W, Zhang J, Gill B, et al. (2003) Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol 107: 103-115.
16. Decallonne B, van Etten E, Giulietti A, Casteels K, Overbergh L, et al. (2003) Defect in activation induced cell death in non-obese diabetic (NOD) T lymphocytes. J Autoimmun 20: 219-226.
17. Yolcu ES, Kaminitz A, Ash S, Sagiv Y, Askenasy N, et al. (2008) Apoptosis as a mechanism of T regulatory cell homeostasis and suppression. Immunol Cell Biol 86: 650-658.
18. Taams LS, Smfith J, Rustin MH, Salmon M, Poulter LW, et al. (2001) Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31: 1122-1131.
19. Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, et al. (2005) In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol 175: 32-36.
20. Glisic-Milosavljevic S, Waukau J, Jailwala P, Jana S, Khoo HJ, et al. (2007) Atrisk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS ONE 2: e146.
21. Jailwala P, Waukau J, Glisic S, Jana S, Ehlenbach S, et al. (2009) Apoptosis of CD4+ CD25high T Cells in Type 1 Diabetes may be partially mediated by IL-2 deprivation. PLoS ONE 4: e6527.
22. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, et al. (2002) Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 109: 131-140.
23. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, et al. (2005) Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
24. Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA (2005) Functional defects and the influence of age on the frequency of CD4+ CD25+ Tcells in type 1 diabetes. Diabetes 54: 1407-1414.
25. Putnam AL, Vendrame F, Dotta F, Gottlieb PA (2005) CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun 24: 55-62.
26. You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, et al. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative agedependent changes in pathogenic T-cells. Diabetes 54: 1415-1422.
27. Mellanby RJ, Thomas D, Phillips JM, Cooke A (2007) Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 121: 15-28.
28. Mohamood AS, Trujillo CJ, Zheng D, Jie C, Murillo FM, et al. (2006) Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+ CD4+ TR cells. Int Immunol 18: 1265-1277.
29. Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, et al. (2000) Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 12: 1145-1155.
30. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A (2002) Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 3: 33-41.
31. Fisson S, Darrasse-Jeze G, Litvinova E, Septier F, Klatzmann D, et al. (2003) Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 198: 737-746.
32. Askenasy N, Yolcu ES, Shirwan H, Stein J, Yaniv I, et al. (2003) Characterization of adhesion and viability of early seeding hematopoietic cells in the host bone marrow in vivo and in situ. Exp Hematol 31: 1292-300.
33. Banz A, Pontoux C, Papiernik M (2002) Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol 169: 750-757.
34. Dalise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, et al. (2008) The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA 105: 19857-19862.
35. Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353: 858-861.
36. Pandiyan P, Lenardo MJ (2008) The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol Direct 3: 6.
37. Yarkoni S, Kaminitz A, Sagiv Y, Yaniv I, Askenasy N (2008) Involvement of IL- 2 in homeostasis of regulatory T cells: the IL-2 cycle. BioEssays 30: 875-888.
38. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, et al. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells. Int Immunol 10: 1969-1980.
39. Thornton AM, Shevach EM (1998) CD4 + CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287-296.
40. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455-1465.
41. Askenasy N, Farkas DL (2002) Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells 20: 501-513.
42. Yolcu ES, Askenasy N, Singh NP, Cherradi SE, Shirwan H (2002) Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity 17: 795-808.
43. Jiang N, Reich CF, 3rd, Pisetsky DS (2003) Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 102: 2243-2250.
44. Asquith B, Borghans JA, Ganusov VV, Macallan DC (2009) Lymphocyte kinetics in health and disease. Trends Immunol 30: 182-189.
45. Glisic-Milosavljevic S, Wang T, Koppen M, Kramer J, Ehlenbach S, et al. (2007) Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes. Clin Exp Immunol 150: 75-82.
46. Klein L, Khazaie K, von Boehmer H (2003) In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 100: 8886-8891.
47. Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, et al. (2008) The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+regulatory T cells. J Immunol 181: 7350-7355.
48. Chen Z, Herman AE, Matos M, Mathis D, Benoist C (2005) Where CD4 + CD25 + T reg cells impinge on autoimmune diabetes. J Exp Med 202: 1387-1397.
49. Pearl-Yafe M, Iskovich S, Kaminitz A, Stein J, Yaniv I, et al. (2006) Does physiological b cell turnover initiate autoimmune diabetes in the regional lymph nodes? Autoimmun Rev 5: 338-343.
50. von Herrath M, Sanda S, Herold K (2007) Type 1 diabetes as a relapsingremitting disease? Nat Rev Immunol 7: 988-994.
51. Bluestone JA, Abbas AK (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253-257.
52. Raimondi G, Turner MS, Thomson AW, Morel PA (2007) Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 27: 61-95.
53. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ (2007) CD4+CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+T cells. Nat Immunol 8: 1353-1362.
54. Malek TR, Bayer AL (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4: 665-674.
55. Nelson BH (2004) IL-2, regulatory T cells, and tolerance. J Immunol 172: 3983-3988.
56. Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
57. Serreze DV, Hamaguchi K, Leiter EH (1989) Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 2: 759-776.
58. Bienvenu B, Martin B, Auffray C, Cordier C, Becourt C, et al. (2005) Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 175: 246-253.
59. Khoruts A, Mondino A, Pape KA, Reiner SL, Jenkins MK (1998) A natural immunological adjuvant enhances T cell clonal expansion through a CD28- dependent, interleukin (IL)-2-independent mechanism. J Exp Med 187: 225-236.
60. Thornton AM, Shevach EM (2000) Suppressor effector function of CD4+ CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164: 183-190.
61. Pearl-Yafe M, Yolcu ES, Stein J, Kaplan O, Yaniv I, et al. (2007) Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells 25: 1448-1455.
62. Yarkoni S, Kaminitz A, Sagiv Y, Askenasy N (2010) Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. Diabetologia 53: 356-368.
63. Kaminitz A, Mizrahi K, Yaniv I, Stein J, Askenasy N (2010) Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells. J Autoimmun 35: 145-152.